November 5, 2007
Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industries, today announced that Ben Bonifant, Vice President of the firm’s Business Development practice, will speak at the Biotechnology Industry Organization’s (
The Advanced BD Course will take place from November 9-11 at the Fairmont Hotel Vier Jahreszeiten. Mr. Bonifant’s workshop, "11 Missteps in Valuation and How to Avoid Them," will discuss some of the more frequently encountered errors in valuation models. The audience will then participate in an interactive discussion of how decision makers can increase the likelihood that the models they rely on reflect the "real world" of pharmaceutical commercialization. The workshop will be conducted on Friday, November 9, from to and will greatly benefit business development professionals interested in bringing their skills in valuation, due diligence, negotiations, and contracts to the next level.
Mr. Bonifant has been a management consultant for nearly 15 years, helping leaders of global pharmaceutical and biotech organizations and decision makers in large private equity funds. His perspectives on developments in the life sciences market are frequently published in industry and strategy journals, and he is a frequent guest lecturer at some of the nation’s premier universities. Mr. Bonifant earned an MBA from the Stanford Graduate School of Business.
For more information on the
Executives from Campbell Alliance speak at many conferences in the
About the Business Development Practice at
The Business Development practice at Campbell Alliance helps licensing executives achieve an edge over the competition. Our consultants provide experienced counsel to clients who need assistance developing BD strategies, identifying partners, prioritizing targets, evaluating opportunities, and negotiating deals.
The firm's team includes seasoned consultants and industry professionals in pharmaceutical and biotech BD who have identified, assessed, and executed numerous in-licensing deals. They have also been valuable in aiding out-licensors, helping clients improve internal processes for pharmaceutical business development, and assisting top executives in charting new strategies in corporate development.
Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries. The firm's clients include most of the world's top 20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in